Lineage Cell Therapeutics In shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $396k | 363k | 1.09 |
| 2023-09-30 | $429k | 363k | 1.18 |
| 2023-06-30 | $512k | 363k | 1.41 |
| 2023-03-31 | $102k | 68k | 1.50 |
| 2022-12-31 | $53k | 46k | 1.17 |
| 2022-09-30 | $52k | 46k | 1.14 |
| 2022-06-30 | $72k | 46k | 1.58 |
| 2022-03-31 | $512k | 332k | 1.54 |
| 2021-12-31 | $773k | 315k | 2.45 |
| 2021-09-30 | $795k | 315k | 2.52 |
| 2021-06-30 | $919k | 322k | 2.85 |
| 2021-03-31 | $114k | 48k | 2.37 |
| 2020-12-31 | $117k | 66k | 1.77 |
| 2020-09-30 | $62k | 66k | 0.94 |
| 2020-06-30 | $58k | 66k | 0.88 |
| 2020-03-31 | $194k | 234k | 0.83 |
| 2019-12-31 | $208k | 234k | 0.89 |
| 2019-09-30 | $229k | 234k | 0.98 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management